🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multicenter, phase Ib/II study of the combination of...
Status
Terminated
Location
Huntsman Cancer Institute at the University of Utah
Start Date
2022-09-23
Trial ID
NCT05405309
The purpose of this study is to test the safety of the study drug, RP-3500 ...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activites)
Start Date
2022-09-30
Trial ID
NCT05566574
Treatments Being Tested
This study is being done to answer the following question: Can testing brea...
Status
Recruiting
Location
Arthur J.E. Child Comprehensive Cancer Centre
Start Date
2023-06-13
Trial ID
NCT05601440
The primary purpose of this study is to define the maximum tolerated dose (...
Status
Completed
Location
#1014, Northwestern University
Start Date
2020-07-22
Trial ID
NCT04497116
Treatments Being Tested
The primary purpose of this study is to assess the safety and tolerability ...
Status
Terminated
Location
Participating Site #1018
Start Date
2021-07-21
Trial ID
NCT04972110
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of camonse...
Status
Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2027-02-13
Trial ID
NCT07156227
The primary purpose of this study is to assess the safety and tolerability ...
Status
Recruiting
Location
# 1019, UCLA, Westwood Cancer Center
Start Date
2021-04-30
Trial ID
NCT04855656
Treatments Being Tested
This study is being done to answer the following questions: * Is the new d...
Status
Completed
Location
BCCA - Kelowna
Start Date
2023-05-24
Trial ID
NCT05605509
Treatments Being Tested